Meiotic synapsis
REACTOME PATHWAYThe Meiotic synapsis pathway (Reactome ID: R-HSA-1221632) involves 2 genes and is affected by 35 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Meiotic synapsis
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | Apigenin 5,7,4'-trihydroxy-flavone, | — | 300 |
| 2 | Resveratrol | — | 298 |
| 3 | Methotrexate | — | 289 |
| 4 | Astemizole Antihistamine drug now withdrawn from | — | 280 |
| 5 | Azacitidine | — | 298 |
| 6 | Azacitidine | — | 300 |
| 7 | Calcimycin | — | 216 |
| 8 | calycosin | — | 300 |
| 9 | Chlorhexidine | — | 299 |
| 10 | Ciclopirox | — | 88 |
| 11 | Colchicine | — | 300 |
| 12 | colchine | — | 2 |
| 13 | cycloheximide | — | 300 |
| 14 | Cytarabine | — | 297 |
| 15 | Demecolcine | — | 246 |
| 16 | Digitoxigenin 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide. | — | 300 |
| 17 | Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide. | — | 300 |
| 18 | dihydrorotenone | — | 13 |
| 19 | Fluspirilene | — | 74 |
| 20 | gedunin | — | 54 |
| 21 | Hexachlorophene | — | 300 |
| 22 | lidoflazine | — | 278 |
| 23 | Melphalan | — | 300 |
| 24 | Niclosamide | — | 299 |
| 25 | Nocodazole Nocodazole is | — | 215 |
| 26 | paxilline | — | 42 |
| 27 | Podophyllotoxin | — | 14 |
| 28 | rafoxanide | — | 172 |
| 29 | Semustine 4-Methyl derivative of LOMUSTINE; (CCNU). | — | 97 |
| 30 | Strophanthidin 3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20(22)-enolide. | — | 300 |
| 31 | Thiabendazole 2-Substituted benzimidazole first introduced in 1962. It is active against | — | 299 |
| 32 | Trifluridine | — | 295 |
| 33 | Tubercidin | — | 300 |
| 34 | vinblastine sulfate | — | 81 |
| 35 | Histamine | — | 300 |
About the Meiotic synapsis Pathway
The Meiotic synapsis pathway is catalogued in Reactome (ID: R-HSA-1221632) and involves 2 genes. In the BiohacksAI corpus, 35 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include BRCA1, LMNA.